University of New Mexico-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of New Mexico - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013565
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of New Mexico (UNM) is an educational service provider that offers bachelors, masters, doctoral and professional degree programs in various fields. The university offers programs such as continuing education, evening and weekend degree programs, extended learning and Latin American studies, among others. It also conducts research studies in fields of intellectual property, technology transfer, and health science. UNM operates a health science center that offers trauma services. The university operates through its colleges including The Robert O. Anderson School of Management, College of Arts and Sciences, College of Education, School of Engineering, College of Fine Arts, and Health Sciences Center, among others. UNM is headquartered in Albuquerque, New Mexico, the US.

University of New Mexico – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of New Mexico, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of New Mexico, Medical Devices Deals, 2011 to YTD 2017 10
University of New Mexico, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University of New Mexico, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
ExoVita Biosciences Enters into Research Agreement with University of New Mexico 12
University Of New Mexico Enters Into Agreement With Biosortia Pharma 13
Licensing Agreements 14
SolaranRx Enters Into Licensing Agreement with University of New Mexico 14
ExoVita Biosciences Enters into Licensing Agreement with University of New Mexico 15
University of New Mexico – Key Competitors 16
University of New Mexico – Key Employees 17
University of New Mexico – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Nov 14, 2017: St. Baldrick’s Foundation Announces $2.2 Million in Grants to Give More Kids Access to Clinical Trials 19
Jul 14, 2017: Biology Professor Receives Funding to Fight Pervasive African Parasite 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
University of New Mexico, Pharmaceuticals & Healthcare, Key Facts 2
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of New Mexico, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of New Mexico, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of New Mexico, Deals By Therapy Area, 2011 to YTD 2017 8
University of New Mexico, Medical Devices Deals, 2011 to YTD 2017 10
University of New Mexico, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
ExoVita Biosciences Enters into Research Agreement with University of New Mexico 12
University Of New Mexico Enters Into Agreement With Biosortia Pharma 13
SolaranRx Enters Into Licensing Agreement with University of New Mexico 14
ExoVita Biosciences Enters into Licensing Agreement with University of New Mexico 15
University of New Mexico, Key Competitors 16
University of New Mexico, Key Employees 17
University of New Mexico, Subsidiaries 18

★海外企業調査レポート[University of New Mexico-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Symbolic Displays, Inc.:企業の戦略・SWOT・財務情報
    Symbolic Displays, Inc. - Strategy, SWOT and Corporate Finance Report Summary Symbolic Displays, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Boule Diagnostics AB (BOUL):医療機器:M&Aディール及び事業提携情報
    Summary Boule Diagnostics AB (Boule) is a medical device company that offers hematology diagnostic solutions. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. It offers products such as blood cell counter and instruments, reagents, calibra …
  • VQ OrthoCare:企業の戦略的SWOT分析
    VQ OrthoCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • The Prudential Insurance Company of America:企業のM&A・事業提携・投資動向
    The Prudential Insurance Company of America - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Prudential Insurance Company of America Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • SMCP S.A.S (SMCP):企業の財務・戦略的SWOT分析
    SMCP S.A.S (SMCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • GVK Power and Infrastructure Ltd (GVKPIL):企業の財務・戦略的SWOT分析
    GVK Power and Infrastructure Ltd (GVKPIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Purdue Pharma L.P.:企業の戦略・SWOT・財務情報
    Purdue Pharma L.P. - Strategy, SWOT and Corporate Finance Report Summary Purdue Pharma L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PNM Resources Inc (PNM):企業の財務・戦略的SWOT分析
    PNM Resources Inc (PNM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Juwi Inc:電力:M&Aディール及び事業提携情報
    Summary Juwi Inc (Juwi), a subsidiary of juwi AG is a renewable energy company that operates wind and solar projects. The company’s services include development and acquisition, engineering, procurement, construction and operations and maintenance. Juwi's operations and maintenance services comprise …
  • Centre for Drug Design and Discovery-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution provides services such as silico molecule design, modelling and screening, medicinal chemistry, intellectual property rights support, business development, …
  • Sfinks Polska S.A.:企業の戦略・SWOT・財務分析
    Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Plus Therapeutics Inc (PSTV):企業の財務・戦略的SWOT分析
    Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Taikisha Ltd
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • The Norwegian Radium Hospital Research Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary The Norwegian Radium Hospital Research Foundation (Radium Hospital) is a research center that conducts research programs and clinical studies. The center invests in oncology, novel therapeutics and diagnostics. It operates as a hub for cancer and oncology treatment research. Radium Hospital …
  • Franz Haniel & Cie. GmbH:企業の戦略・SWOT・財務情報
    Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report Summary Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析
    Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nuri Telecom Co., Ltd. (040160):企業の財務・戦略的SWOT分析
    Nuri Telecom Co., Ltd. (040160) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Orano SA:電力:M&Aディール及び事業提携情報
    Summary Orano SA (Orano), formerly New AREVA Holding, is an integrated nuclear energy company that transforms nuclear materials and provides technological solutions for power generation and allied services. It offers complete range of products and services that covers the entire nuclear fuel cycle r …
  • Sol-Gel Technologies Ltd (SLGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Sol-Gel Technologies Ltd (Sol-Gel) is a clinical-stage dermatology company that identifies, develops and commercializes branded and generic topical dermatological drug products for the treatment of skin diseases. The company’s pipeline products include vered, twin and sirs-t drug candidates. …
  • Universal Travel Group:企業の戦略・SWOT・財務分析
    Universal Travel Group - Strategy, SWOT and Corporate Finance Report Summary Universal Travel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆